<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0120-8748</journal-id>
<journal-title><![CDATA[Acta Neurológica Colombiana]]></journal-title>
<abbrev-journal-title><![CDATA[Acta Neurol Colomb.]]></abbrev-journal-title>
<issn>0120-8748</issn>
<publisher>
<publisher-name><![CDATA[Asociación Colombiana de Neurología]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0120-87482019000300156</article-id>
<article-id pub-id-type="doi">10.22379/24224022262</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Trombólisis endovenosa como tratamiento del ACV isquémico agudo en Colombia: una revisión sistemática de la literatura]]></article-title>
<article-title xml:lang="en"><![CDATA[Intravenous thrombolysis as treatment of acute ischemic stroke in Colombia: a systematic review of literature]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Moreno]]></surname>
<given-names><![CDATA[Eder]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[Jaime]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
<xref ref-type="aff" rid="A a"/>
<xref ref-type="aff" rid="A3"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Bayona-Ortiz]]></surname>
<given-names><![CDATA[Hernán]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
<xref ref-type="aff" rid="A a"/>
<xref ref-type="aff" rid="A3"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Universitario Fundación Santa Fe Departamento de Neurología ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad de los Andes Facultad de Medicina ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad El Bosque Facultad de Medicina ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>09</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>09</month>
<year>2019</year>
</pub-date>
<volume>35</volume>
<numero>3</numero>
<fpage>156</fpage>
<lpage>166</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0120-87482019000300156&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0120-87482019000300156&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0120-87482019000300156&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  INTRODUCCIÓN: En Colombia el ataque cerebrovascular isquémico es la primera causa de discapacidad y la tercera causa de muerte, el uso oportuno de rt-PA puede mejorar su pronóstico.  OBJETIVOS: Conocer la experiencia de centros acerca del uso de trombolíticos para el ACV en Colombia, a fin de establecer brechas de atención y oportunidades de mejoría.  MÉTODOS: Se hizo revisión sistemática utilizando Google, Google Académico, PubMed, Scielo, así como otras fuentes de literatura gris para las publicaciones sobre trombólisis en Colombia, con un análisis de la calidad de los estudios, así como un registro de tiempos de atención, escalas utilizadas y medidas de desenlace.  RESULTADOS: Al final se obtuvieron seis estudios, con 179 sujetos que recibieron trombólisis. Todos los estudios cumplieron con los requisitos mínimos de calidad de publicación, con un número total de pacientes por año de 7,5 a 12. El periodo de estudio más corto fue de dos años y el más largo de ocho años. Entre cuatro ciudades encontradas se estableció que un total de 30 pacientes por año recibió el tratamiento. Tan solo en dos estudios se pudo establecer el porcentaje de pacientes trombolizados en su población, porcentaje que oscilaba entre 9,5 y 17,5 %. El tiempo puerta aguja promedio de los estudios fue de 124,8 min (DE ± 64,1). A los 90 días se obtuvo un promedio de 58,3 % de escala de Rankin modificada entre 0 y 2 puntos.  CONCLUSIÓN: En Colombia existe un subregistro de trombólisis. Es necesario tener un registro nacional de ACV que permita contar con la información para la toma de decisiones en políticas en salud.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[SUMMARY  INTRODUCTION: Ischemic stroke is the leading cause of disability and the third cause of death, timely use of rt-PA can improve prognosis.  OBJECTIVES: To know the experience of centers about the use of thrombolytic therapy for stroke in Colombia. To establish attention gaps and opportunities for improvement.  METHODS: A systematic review was made using Google, Google Scholar, Pubmed, Scielo, as well as other sources of gray literature for publications on thrombolysis in Colombia. With an analysis of the quality of the studies, as well as a record of attention times, scales used and outcome measures.  RESULTS: Six studies were obtained at the end, with 179 subjects who received thrombolysis. All the studies met the minimum quality requirements for publication. A total number of patients per year between 7.5 to 12. The shortest study period was 2 years and the longest was 8 years. Among 4 cities found, it was established that a total of 30 patients / year received the treatment. In only two studies was possible to establish the percentage of thrombolysis patients in their population that ranged from 9.5 to 17.5 %. The average Door to Needle Time for the studies was 124.8 minutes (SD ± 64.1). After 90 days, an average of 58.3 % of modified Rankin scale was obtained between 0-2 points.  CONCLUSION: There is an underreporting of thrombolysis in Colombia. It is necessary to have a national registry of stroke that allows us having the information for decision making in health policies.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[accidente cerebrovascular]]></kwd>
<kwd lng="es"><![CDATA[terapia trombolítica]]></kwd>
<kwd lng="es"><![CDATA[pronóstico]]></kwd>
<kwd lng="es"><![CDATA[mortalidad]]></kwd>
<kwd lng="es"><![CDATA[Colombia (DeCS)]]></kwd>
<kwd lng="en"><![CDATA[stroke]]></kwd>
<kwd lng="en"><![CDATA[thrombolytic therapy]]></kwd>
<kwd lng="en"><![CDATA[prognosis]]></kwd>
<kwd lng="en"><![CDATA[mortality]]></kwd>
<kwd lng="en"><![CDATA[Colombia (MeSH)]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Van der Worp]]></surname>
<given-names><![CDATA[HB]]></given-names>
</name>
<name>
<surname><![CDATA[van Gijn]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical practice. Acute ischemic stroke]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2007</year>
<volume>357</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>572-9</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lavados]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Sacks]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[l]]></surname>
<given-names><![CDATA[Prina]]></given-names>
</name>
<name>
<surname><![CDATA[Escobar]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Tossi]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Araya]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Incidence, case- fatality rate, and prognosis of ischemic stroke subtypes in predominantly hispanic-mestizo population in iquique, chile (piscis project): A community based incidence study]]></article-title>
<source><![CDATA[Lancet Neurol]]></source>
<year>2007</year>
<volume>6</volume>
<page-range>140-8</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castañeda Cardona]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Coral Casas]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Rueda]]></surname>
<given-names><![CDATA[M. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz Cortes]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Experiencia de trombólisis intravenosa en el manejo del ataque cerebro vascular en el Hospital Universitario San Ignacio 2011-2013 (EXTRO HUSI)]]></article-title>
<source><![CDATA[Acta Neurológica Colombiana]]></source>
<year>2014</year>
<volume>30</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>16-21</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[von Kummer]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Broderick]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[Campbell]]></surname>
<given-names><![CDATA[BC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Heidelberg Bleeding Classification: classification of bleeding events after ischemic stroke and reperfusión therapy]]></article-title>
<source><![CDATA[Stroke]]></source>
<year>2015</year>
<volume>46</volume>
<page-range>2981-6</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gomes]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Chalela]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Stroke in the Tropics]]></article-title>
<source><![CDATA[Semin Neurol]]></source>
<year>2005</year>
<volume>25</volume>
<page-range>290-9</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Uribe]]></surname>
<given-names><![CDATA[CS]]></given-names>
</name>
<name>
<surname><![CDATA[Jimenez]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Mora]]></surname>
<given-names><![CDATA[MO]]></given-names>
</name>
<name>
<surname><![CDATA[Arana]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Zuluaga]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiología de las enfermedades cerebrovasculares en Sabaneta, Colombia (1992-1993)]]></article-title>
<source><![CDATA[Rev Neurol]]></source>
<year>1997</year>
<volume>25</volume>
<page-range>1008-12</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pradilla]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Boris]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Vesga]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Fidias]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<collab>León-Sarmiento</collab>
<collab>Grupo Geneco</collab>
<source><![CDATA[Estudio neuroepidemiológico nacional (EPINEURO) colombiano]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<collab>Tissue plasminogen activator for acute ischemic stroke</collab>
<article-title xml:lang=""><![CDATA[The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>1995</year>
<volume>333</volume>
<numero>24</numero>
<issue>24</issue>
<page-range>1581-7</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wahlgren]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Ahmed]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Dávalos]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Ford]]></surname>
<given-names><![CDATA[G. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Grond]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Hacke]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study]]></article-title>
<source><![CDATA[The Lancet]]></source>
<year>2007</year>
<volume>369</volume>
<numero>9558</numero>
<issue>9558</issue>
<page-range>275-82</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wahlgren]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Ahmed]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Dávalos]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Hacke]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
<name>
<surname><![CDATA[Millán]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Muir]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Thrombolysis with altepl ase 3-1--5 h after acute ischaemic stroke (SITS-ISTR): an observational study]]></article-title>
<source><![CDATA[The Lancet]]></source>
<year>2008</year>
<volume>372</volume>
<numero>9646</numero>
<issue>9646</issue>
<page-range>1303-9</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Meza]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Causas de no trombolisis en ataque cerebrovascular]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Amaya]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Restrepo]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<source><![CDATA[Acta Neurol Colomb]]></source>
<year>2013</year>
<volume>29</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>4-9</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hacke]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Kaste]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bluhmki]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Brozman]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Dávalos]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Guidetti]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[ECASS Investigators. Thrombolysis with Alteplase 3 to 4.5 hours after Acute Ischemic Stroke]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2008</year>
<volume>359</volume>
<numero>13</numero>
<issue>13</issue>
<page-range>1317-29</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Muñoz Collazos]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gutiérrez]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Londoño]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Bayona]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Herrán]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Perez]]></surname>
<given-names><![CDATA[GE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Stroke in Colombia: a cost-effectiveness study]]></article-title>
<source><![CDATA[Acta Neurol Colomb]]></source>
<year>2008</year>
<volume>25</volume>
<page-range>158-73</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pardo]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guía de práctica clínica para el diagnóstico, tratamiento y rehabilitación del episodio agudo de ataque cerebrovascular en población mayor de 18 años: de las recomendaciones a su implementación]]></article-title>
<source><![CDATA[Acta Neurológica Colombiana]]></source>
<year>2016</year>
<volume>31</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>462-7</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Correa]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Puerto]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Viracacha]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<collab>FEPAFEM</collab>
<source><![CDATA[GUÍAS PARA MANEJO DE URGENCIAS 3a EDICION TOMO I. In Ministerio de salud]]></source>
<year>2009</year>
<volume>3</volume>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Berkhemer]]></surname>
<given-names><![CDATA[O. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Fransen]]></surname>
<given-names><![CDATA[P. S. S.]]></given-names>
</name>
<name>
<surname><![CDATA[Beumer]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[van den Berg]]></surname>
<given-names><![CDATA[L. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Lingsma]]></surname>
<given-names><![CDATA[H. F.]]></given-names>
</name>
<name>
<surname><![CDATA[Yoo]]></surname>
<given-names><![CDATA[A. J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke]]></article-title>
<source><![CDATA[New England Journal of Medicine]]></source>
<year>2015</year>
<volume>372</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>11-20</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Campbell]]></surname>
<given-names><![CDATA[B. C. V.]]></given-names>
</name>
<name>
<surname><![CDATA[Mitchell]]></surname>
<given-names><![CDATA[P. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Kleinig]]></surname>
<given-names><![CDATA[T. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Dewey]]></surname>
<given-names><![CDATA[H. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Churilov]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Yassi]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection]]></article-title>
<source><![CDATA[New England Journal of Medicine]]></source>
<year>2015</year>
<volume>372</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1009-18</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Goyal]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Demchuk]]></surname>
<given-names><![CDATA[A. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Menon]]></surname>
<given-names><![CDATA[B. K.]]></given-names>
</name>
<name>
<surname><![CDATA[Eesa]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Rempel]]></surname>
<given-names><![CDATA[J. L.]]></given-names>
</name>
<name>
<surname><![CDATA[Thornton]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke]]></article-title>
<source><![CDATA[New England Journal of Medicine]]></source>
<year>2015</year>
<volume>372</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1019-30</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saver]]></surname>
<given-names><![CDATA[J. L.]]></given-names>
</name>
<name>
<surname><![CDATA[Goyal]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Bonafe]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Diener]]></surname>
<given-names><![CDATA[H.-C.]]></given-names>
</name>
<name>
<surname><![CDATA[Levy]]></surname>
<given-names><![CDATA[E. I.]]></given-names>
</name>
<name>
<surname><![CDATA[Pereira]]></surname>
<given-names><![CDATA[V. M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Stent-Retriever Thrombec-tomy after Intravenous t-PA vs. t-PA Alone in Stroke]]></article-title>
<source><![CDATA[New England Journal of Medicine]]></source>
<year>2015</year>
<volume>372</volume>
<numero>24</numero>
<issue>24</issue>
<page-range>2285-95</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jovin]]></surname>
<given-names><![CDATA[T. G.]]></given-names>
</name>
<name>
<surname><![CDATA[Chamorro]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Cobo]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[de Miquel]]></surname>
<given-names><![CDATA[M. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Molina]]></surname>
<given-names><![CDATA[C. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Rovira]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Thrombectomy within 8 Hours after Symptom Onset in Ischemic Stroke]]></article-title>
<source><![CDATA[New England Journal of Medicine]]></source>
<year>2015</year>
<volume>372</volume>
<numero>24</numero>
<issue>24</issue>
<page-range>2296-306</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bracard]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Ducrocq]]></surname>
<given-names><![CDATA[X.]]></given-names>
</name>
<name>
<surname><![CDATA[Mas]]></surname>
<given-names><![CDATA[J. L.]]></given-names>
</name>
<name>
<surname><![CDATA[Soudant]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Oppen-heim]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Moulin]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial]]></article-title>
<source><![CDATA[The Lancet Neurology]]></source>
<year>2016</year>
<volume>15</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1138-47</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Muir]]></surname>
<given-names><![CDATA[K. W.]]></given-names>
</name>
<name>
<surname><![CDATA[Ford]]></surname>
<given-names><![CDATA[G. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Messow]]></surname>
<given-names><![CDATA[C.-M.]]></given-names>
</name>
<name>
<surname><![CDATA[Ford]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Murray]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Clifton]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised, controlled trial]]></article-title>
<source><![CDATA[Journal of Neurology, Neurosurgery &amp; Psychiatry]]></source>
<year>2016</year>
<volume>88</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>38-44</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nogueira]]></surname>
<given-names><![CDATA[R. G.]]></given-names>
</name>
<name>
<surname><![CDATA[Jadhav]]></surname>
<given-names><![CDATA[A. P.]]></given-names>
</name>
<name>
<surname><![CDATA[Haussen]]></surname>
<given-names><![CDATA[D. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Bonafe]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Budzik]]></surname>
<given-names><![CDATA[R. F.]]></given-names>
</name>
<name>
<surname><![CDATA[Bhuva]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct]]></article-title>
<source><![CDATA[New England Journal of Medicine]]></source>
<year>2018</year>
<volume>378</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>11-21</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Hours after Stroke with a Mismatch between Deficit and Infarct]]></article-title>
<source><![CDATA[New England Journal of Medicine]]></source>
<year></year>
<volume>378</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>11-21</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Albers]]></surname>
<given-names><![CDATA[G. W.]]></given-names>
</name>
<name>
<surname><![CDATA[Marks]]></surname>
<given-names><![CDATA[M. P.]]></given-names>
</name>
<name>
<surname><![CDATA[Kemp]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Christensen]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Tsai]]></surname>
<given-names><![CDATA[J. P.]]></given-names>
</name>
<name>
<surname><![CDATA[Ortega-Gutierrez]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging]]></article-title>
<source><![CDATA[New England Journal of Medicine]]></source>
<year>2018</year>
<volume>378</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>708-18</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ma]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Campbell]]></surname>
<given-names><![CDATA[B. C. V.]]></given-names>
</name>
<name>
<surname><![CDATA[Parsons]]></surname>
<given-names><![CDATA[M. W.]]></given-names>
</name>
<name>
<surname><![CDATA[Churilov]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Levi]]></surname>
<given-names><![CDATA[C. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Hsu]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke]]></article-title>
<source><![CDATA[New England Journal of Medicine]]></source>
<year>2019</year>
<volume>380</volume>
<numero>19</numero>
<issue>19</issue>
<page-range>1795-803</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thomalla]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Gerloff]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Acute imaging for evidence-based treatment of ischemic stroke]]></article-title>
<source><![CDATA[Current Opinion in Neurology]]></source>
<year>2019</year>
<volume>1</volume>
</nlm-citation>
</ref>
<ref id="B28">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pineda]]></surname>
<given-names><![CDATA[D. A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Trombólisis con tratamiento con activador recombinante del plasminógeno tisular (rt-PA) para el ataque cerebro vascular agudo: la experiencia colombiana]]></article-title>
<source><![CDATA[Acta Neurológica Colombiana]]></source>
<year>2017</year>
<volume>33</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-2</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Liberati]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Altman]]></surname>
<given-names><![CDATA[DG]]></given-names>
</name>
<name>
<surname><![CDATA[Tetzlaff]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Mulrow]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Gotzsche]]></surname>
<given-names><![CDATA[PC]]></given-names>
</name>
<name>
<surname><![CDATA[Ioannidis]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventios]]></article-title>
<source><![CDATA[Explanation an elaboration BMJ]]></source>
<year>2009</year>
<volume>339</volume>
<numero>B2700</numero>
<issue>B2700</issue>
</nlm-citation>
</ref>
<ref id="B30">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guerrero-Gonzalez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Serna]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Gamez]]></surname>
<given-names><![CDATA[DX]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Experiencia de trombolisis intravenosa en infarto cerebral agudo en un Hospital Universitario en Cali. Resumenes XXIII Congreso Colombiano de Medicina Interna 2014]]></article-title>
<source><![CDATA[Acta Medica Colombiana]]></source>
<year></year>
<volume>39</volume>
<numero>2^s1</numero>
<issue>2^s1</issue>
<supplement>1</supplement>
<page-range>182</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>30</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martinez-Villota]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Checa]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<source><![CDATA[Trombólisis Endovenosa en ACV isquémico en Nariño. Poster congreso Nacional Neurología]]></source>
<year>2017</year>
<publisher-loc><![CDATA[Nariño ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B32">
<label>31</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wells]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Shea]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[O'Connell]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Peterson]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Welch]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Losos]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in metaanalyses]]></source>
<year>2000</year>
</nlm-citation>
</ref>
<ref id="B33">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bayona-Ortíz]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz-Cruz]]></surname>
<given-names><![CDATA[C. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Góez-Mogollón]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Useche-Gómez]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Valencia-Mendoza]]></surname>
<given-names><![CDATA[M. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Jeanneret López]]></surname>
<given-names><![CDATA[et.al]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Observational study of thrombolytic treatment for acute stroke in patients older and younger than 80 years: experience from one hospital in Bogotá, Colombia, 2007-2014]]></article-title>
<source><![CDATA[Revista Médicas UIS]]></source>
<year>2017</year>
<volume>30</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>21-30</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hernández E.]]></surname>
<given-names><![CDATA[Guarín E.]]></given-names>
</name>
<name>
<surname><![CDATA[Lora F.]]></surname>
<given-names><![CDATA[Acosta J.]]></given-names>
</name>
<name>
<surname><![CDATA[Beltrán E.]]></surname>
<given-names><![CDATA[N. M. C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Trombólisis intravenosa en pacientes con accidente cerebrovascular isquémico: Experiencia de un Hospital del Caribe Colombiano]]></article-title>
<source><![CDATA[Acta Neurologica Colombiana]]></source>
<year>2017</year>
<volume>374</volume>
<numero>24</numero>
<issue>24</issue>
<page-range>2389-90</page-range></nlm-citation>
</ref>
<ref id="B35">
<label>34</label><nlm-citation citation-type="journal">
<collab>European Stroke Organisation (ESO)</collab>
<article-title xml:lang=""><![CDATA[Executive Committee, ESO Writing Committee. Guidelines for management of isch-aemic stroke and transient ischaemic attack 2008]]></article-title>
<source><![CDATA[Cerebrovasc Dis]]></source>
<year>2008</year>
<volume>25</volume>
<page-range>457-507</page-range></nlm-citation>
</ref>
<ref id="B36">
<label>35</label><nlm-citation citation-type="">
<source><![CDATA[Sistema de Información Territorial en Accidente Cerebrovascular (SITAC)]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B37">
<label>36</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McDermott]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Skolarus]]></surname>
<given-names><![CDATA[L. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Burke]]></surname>
<given-names><![CDATA[J. F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A systematic review and meta-analysis of interventions to increase stroke thrombolysis]]></article-title>
<source><![CDATA[BMC Neurology]]></source>
<year>2019</year>
<volume>19</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B38">
<label>37</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Steiner]]></surname>
<given-names><![CDATA[M. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Brainin]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The quality of acute stroke units on a nation-wide level: the Austrian Stroke Registry for acute stroke units]]></article-title>
<source><![CDATA[European Journal of Neurology]]></source>
<year>2003</year>
<volume>10</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>353-60</page-range></nlm-citation>
</ref>
<ref id="B39">
<label>38</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fang]]></surname>
<given-names><![CDATA[M. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Cutler]]></surname>
<given-names><![CDATA[D. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Rosen]]></surname>
<given-names><![CDATA[A. B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Trends in thrombolytic use for ischemic stroke in the United States]]></article-title>
<source><![CDATA[Journal of Hospital Medicine]]></source>
<year>2010</year>
<volume>5</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>406-9</page-range></nlm-citation>
</ref>
<ref id="B40">
<label>39</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Estol]]></surname>
<given-names><![CDATA[C. J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Stroke in Argentina]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Rojas]]></surname>
<given-names><![CDATA[M. M]]></given-names>
</name>
</person-group>
<source><![CDATA[International Journal of Stroke]]></source>
<year>2010</year>
<volume>5</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>35-9</page-range></nlm-citation>
</ref>
<ref id="B41">
<label>40</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sposato]]></surname>
<given-names><![CDATA[L. A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Quality of Ischemic Stroke Care in Emerging Countries: The Argentinian National Stroke Registry (ReNACer)]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Esnaola]]></surname>
<given-names><![CDATA[M. M]]></given-names>
</name>
<name>
<surname><![CDATA[Zamora]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Zurru]]></surname>
<given-names><![CDATA[M. C]]></given-names>
</name>
</person-group>
<source><![CDATA[Stroke]]></source>
<year>2008</year>
<volume>39</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>3036-41</page-range></nlm-citation>
</ref>
<ref id="B42">
<label>41</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Scherf]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Limburg]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Wimmers]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Middelkoop]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Lingsma]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Increase in national intravenous thrombolysis rates for ischaemic stroke between 2005 and 2012: is bigger better?]]></article-title>
<source><![CDATA[BMC Neurology]]></source>
<year>2016</year>
<volume>16</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B43">
<label>42</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lees]]></surname>
<given-names><![CDATA[K. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Ford]]></surname>
<given-names><![CDATA[G. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Muir]]></surname>
<given-names><![CDATA[K. W]]></given-names>
</name>
<name>
<surname><![CDATA[Ahmed]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Dyker]]></surname>
<given-names><![CDATA[A. G.]]></given-names>
</name>
<name>
<surname><![CDATA[Atula]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Thrombolytic therapy for acute stroke in the United Kingdom: experience from the safe implementation of thrombolysis in stroke (SITS) register]]></article-title>
<source><![CDATA[QJM]]></source>
<year>2008</year>
<volume>101</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>863-9</page-range></nlm-citation>
</ref>
<ref id="B44">
<label>43</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reeves]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bhatt]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Jajou]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sex differences in the use of intravenous rt-PA thrombolysis treatment for acute ischemic stroke: a meta-analysis]]></article-title>
<source><![CDATA[Stroke]]></source>
<year>2009</year>
<volume>40</volume>
<page-range>1743-9</page-range></nlm-citation>
</ref>
<ref id="B45">
<label>44</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hsieh]]></surname>
<given-names><![CDATA[F.-I.]]></given-names>
</name>
<name>
<surname><![CDATA[Chiou]]></surname>
<given-names><![CDATA[H.-Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Stroke: Morbidity, Risk Factors, and Care in Taiwan]]></article-title>
<source><![CDATA[Journal of Stroke]]></source>
<year>2014</year>
<volume>16</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>59</page-range></nlm-citation>
</ref>
<ref id="B46">
<label>45</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Merkler]]></surname>
<given-names><![CDATA[A. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Salehi Omran]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Gialdini]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Lerario]]></surname>
<given-names><![CDATA[M. P.]]></given-names>
</name>
<name>
<surname><![CDATA[Yaghi]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Elkind]]></surname>
<given-names><![CDATA[M. S. V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Safety Outcomes After Thrombolysis for Acute Ischemic Stroke in Patients With Recent Stroke]]></article-title>
<source><![CDATA[Stroke]]></source>
<year>2017</year>
<volume>48</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>2282-4</page-range></nlm-citation>
</ref>
<ref id="B47">
<label>46</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lange]]></surname>
<given-names><![CDATA[M. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Braga]]></surname>
<given-names><![CDATA[G. P.]]></given-names>
</name>
<name>
<surname><![CDATA[Nóvak]]></surname>
<given-names><![CDATA[E. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Harger]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Felippe]]></surname>
<given-names><![CDATA[M. J. D. B.]]></given-names>
</name>
<name>
<surname><![CDATA[Canever]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Key performance indicators for stroke from the Ministry of Health of Brazil: benchmarking and indicator parameters]]></article-title>
<source><![CDATA[Arquivos de Neuro-Psiquiatria]]></source>
<year>2017</year>
<volume>75</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>354-8</page-range></nlm-citation>
</ref>
<ref id="B48">
<label>47</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moro]]></surname>
<given-names><![CDATA[C. H. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Gonçalves]]></surname>
<given-names><![CDATA[A. R. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Longo]]></surname>
<given-names><![CDATA[A. L.]]></given-names>
</name>
<name>
<surname><![CDATA[Fonseca]]></surname>
<given-names><![CDATA[P. G.]]></given-names>
</name>
<name>
<surname><![CDATA[Harger]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Gomes]]></surname>
<given-names><![CDATA[D. B.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Trends of the Incidence of Ischemic Stroke Thrombolysis over Seven Years and One-Year Outcome: A Population-Based Study in Joinville, Brazil]]></article-title>
<source><![CDATA[Cerebrovascular Diseases Extra]]></source>
<year>2013</year>
<volume>3</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>156-66</page-range></nlm-citation>
</ref>
<ref id="B49">
<label>48</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hawkes]]></surname>
<given-names><![CDATA[M. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Carpani]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Farez]]></surname>
<given-names><![CDATA[M. F.]]></given-names>
</name>
<name>
<surname><![CDATA[Ameriso]]></surname>
<given-names><![CDATA[S. F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Door-to-Needle Time in Acute Stroke Treatment and the "July Effect."]]></article-title>
<source><![CDATA[The Neurohospitalist]]></source>
<year>2017</year>
<volume>8</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>24-8</page-range></nlm-citation>
</ref>
<ref id="B50">
<label>49</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Soto V]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Morales I]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Grandjean B]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Pollak W]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[del Castillo C]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[García F]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evolución del protocolo de trombolisis endovenosa en ataque cerebrovascular isquémico agudo]]></article-title>
<source><![CDATA[Revista Médica de Chile]]></source>
<year>2017</year>
<volume>145</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>468-75</page-range></nlm-citation>
</ref>
<ref id="B51">
<label>50</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Audebert]]></surname>
<given-names><![CDATA[H. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Saver]]></surname>
<given-names><![CDATA[J. L.]]></given-names>
</name>
<name>
<surname><![CDATA[Starkman]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Lees]]></surname>
<given-names><![CDATA[K. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Endres]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prehospital stroke care: New prospects for treatment and clinical research]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2013</year>
<volume>81</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>501-8</page-range></nlm-citation>
</ref>
<ref id="B52">
<label>51</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Menéndez Ramírez]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Navarrete Aldana]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Paz Velilla]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tiempos de respuesta del sistema prehospitalario en pacientes con sospecha diagnóstica de ataque cerebral en Bogotá durante los años 2013 y 2014]]></article-title>
<source><![CDATA[Acta Neurológica Colombiana]]></source>
<year>2017</year>
<volume>33</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>135-41</page-range></nlm-citation>
</ref>
<ref id="B53">
<label>52</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials]]></article-title>
<source><![CDATA[The Lancet]]></source>
<year>2004</year>
<volume>363</volume>
<numero>9411</numero>
<issue>9411</issue>
<page-range>768-74</page-range></nlm-citation>
</ref>
<ref id="B54">
<label>53</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lees]]></surname>
<given-names><![CDATA[K. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Bluhmki]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[von Kummer]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Brott]]></surname>
<given-names><![CDATA[T. G.]]></given-names>
</name>
<name>
<surname><![CDATA[Toni]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Grotta]]></surname>
<given-names><![CDATA[J. C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials]]></article-title>
<source><![CDATA[The Lancet]]></source>
<year>2010</year>
<volume>375</volume>
<numero>9727</numero>
<issue>9727</issue>
<page-range>1695-703</page-range></nlm-citation>
</ref>
<ref id="B55">
<label>54</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fonarow]]></surname>
<given-names><![CDATA[G. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[E. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Saver]]></surname>
<given-names><![CDATA[J. L.]]></given-names>
</name>
<name>
<surname><![CDATA[Reeves]]></surname>
<given-names><![CDATA[M. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Hernandez]]></surname>
<given-names><![CDATA[A. F.]]></given-names>
</name>
<name>
<surname><![CDATA[Peterson]]></surname>
<given-names><![CDATA[E. D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Improving Door-to-Needle Times in Acute Ischemic Stroke: The Design and Rationale for the American Heart Association/American Stroke Association's Target: Stroke Initiative]]></article-title>
<source><![CDATA[Stroke]]></source>
<year>2011</year>
<volume>42</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>2983-9</page-range></nlm-citation>
</ref>
<ref id="B56">
<label>55</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tveiten]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Mygland]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Ljostad]]></surname>
<given-names><![CDATA[U.]]></given-names>
</name>
<name>
<surname><![CDATA[Thomassen]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Intravenous thrombolysis for ischaemic stroke: short delays and high community-based treatment rates after organisational changes in a previously inexperienced centre]]></article-title>
<source><![CDATA[Emergency Medicine Journal]]></source>
<year>2009</year>
<volume>26</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>324-6</page-range></nlm-citation>
</ref>
<ref id="B57">
<label>56</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[S. K.]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[S. Y]]></given-names>
</name>
<name>
<surname><![CDATA[Bae]]></surname>
<given-names><![CDATA[H. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[Y S.]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[S. Y]]></given-names>
</name>
<name>
<surname><![CDATA[Kang]]></surname>
<given-names><![CDATA[M. J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pre-hospital notification reduced the door-to-needle time for iv t-PA in acute ischaemic stroke]]></article-title>
<source><![CDATA[European Journal of Neurology]]></source>
<year>2009</year>
<volume>16</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1331-5</page-range></nlm-citation>
</ref>
<ref id="B58">
<label>57</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schwamm]]></surname>
<given-names><![CDATA[L. H.]]></given-names>
</name>
<name>
<surname><![CDATA[Pancioli]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Acker]]></surname>
<given-names><![CDATA[J. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Goldstein]]></surname>
<given-names><![CDATA[L. B.]]></given-names>
</name>
<name>
<surname><![CDATA[Zorowitz]]></surname>
<given-names><![CDATA[R. D.]]></given-names>
</name>
<name>
<surname><![CDATA[Shephard]]></surname>
<given-names><![CDATA[T. J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Recommendations for the Establishment of Stroke Systems of Care]]></article-title>
<source><![CDATA[Stroke]]></source>
<year>2005</year>
<volume>36</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>690-703</page-range></nlm-citation>
</ref>
<ref id="B59">
<label>58</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ruff]]></surname>
<given-names><![CDATA[I. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Ali]]></surname>
<given-names><![CDATA[S. F.]]></given-names>
</name>
<name>
<surname><![CDATA[Goldstein]]></surname>
<given-names><![CDATA[J. N.]]></given-names>
</name>
<name>
<surname><![CDATA[Lev]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Copen]]></surname>
<given-names><![CDATA[W. A.]]></given-names>
</name>
<name>
<surname><![CDATA[McIntyre]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Schwamm]]></surname>
<given-names><![CDATA[L. H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Improving Door-to-Needle Times: A Single Center Validation of the Target Stroke Hypothesis]]></article-title>
<source><![CDATA[Stroke]]></source>
<year>2014</year>
<volume>45</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>504-8</page-range></nlm-citation>
</ref>
<ref id="B60">
<label>59</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lindsberg]]></surname>
<given-names><![CDATA[P. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Happola]]></surname>
<given-names><![CDATA[O.]]></given-names>
</name>
<name>
<surname><![CDATA[Kallela]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Valanne]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Kuisma]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Kaste]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Door to thrombolysis: ER reorganization and reduced delays to acute stroke treatment.]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2006</year>
<volume>67</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>334-6</page-range></nlm-citation>
</ref>
<ref id="B61">
<label>60</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mehdiratta]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Woolfenden]]></surname>
<given-names><![CDATA[A. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Chapman]]></surname>
<given-names><![CDATA[K. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Johnston]]></surname>
<given-names><![CDATA[D. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Schulzer]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Beckman]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reduction in IV t-PA Door to Needle Times Using an Acute Stroke Triage Pathway]]></article-title>
<source><![CDATA[Canadian Journal of Neurological Sciences / Journal Canadien Des Sciences Neurologiques]]></source>
<year>2006</year>
<volume>33</volume>
<numero>02</numero>
<issue>02</issue>
<page-range>214-6</page-range></nlm-citation>
</ref>
<ref id="B62">
<label>61</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fonarow]]></surname>
<given-names><![CDATA[G. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Zhao]]></surname>
<given-names><![CDATA[X.]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[E. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Saver]]></surname>
<given-names><![CDATA[J. L.]]></given-names>
</name>
<name>
<surname><![CDATA[Reeves]]></surname>
<given-names><![CDATA[M. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Bhatt]]></surname>
<given-names><![CDATA[D. L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Door-to-Needle Times for Tissue Plasminogen Activator Administration and Clinical Outcomes in Acute Ischemic Stroke Before and After a Quality Improvement Initiative]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>2014</year>
<volume>311</volume>
<numero>16</numero>
<issue>16</issue>
<page-range>1632</page-range></nlm-citation>
</ref>
<ref id="B63">
<label>62</label><nlm-citation citation-type="">
<source><![CDATA[NIH Stroke Scale - National Stroke Association]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B64">
<label>63</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Quinn]]></surname>
<given-names><![CDATA[T. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Dawson]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Walters]]></surname>
<given-names><![CDATA[M. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Lees]]></surname>
<given-names><![CDATA[K. R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reliability of the Modified Rankin Scale: A Systematic Review]]></article-title>
<source><![CDATA[Stroke]]></source>
<year>2009</year>
<volume>40</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>3393-5</page-range></nlm-citation>
</ref>
<ref id="B65">
<label>64</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rivero-Arias]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Ouellet]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gray]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Wolstenholme]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Rothwell]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
<name>
<surname><![CDATA[Luengo-Fernandez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mapping the modified Rankin scale (mRS) measurement into the generic EuroQol (EQ-5D) health outcome]]></article-title>
<source><![CDATA[Med Decis Making]]></source>
<year>2010</year>
<volume>30</volume>
<page-range>341-54</page-range></nlm-citation>
</ref>
<ref id="B66">
<label>65</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Broderick]]></surname>
<given-names><![CDATA[J. P.]]></given-names>
</name>
<name>
<surname><![CDATA[Adeoye]]></surname>
<given-names><![CDATA[O.]]></given-names>
</name>
<name>
<surname><![CDATA[Elm]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evolution of the Modified Rankin Scale and Its Use in Future Stroke Trials]]></article-title>
<source><![CDATA[Stroke]]></source>
<year>2017</year>
<volume>48</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>2007-12</page-range></nlm-citation>
</ref>
<ref id="B67">
<label>66</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chwojnicki]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Kozera]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Sobolewski]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Fryze]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Nyka]]></surname>
<given-names><![CDATA[W. M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Intravenous thrombolysis and three-year isch-emic stroke mortality]]></article-title>
<source><![CDATA[Acta Neurologica Scandinavica]]></source>
<year>2016</year>
<volume>135</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>540-5</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
